In-licensing
Up-to-date access to technology licensing opportunities worldwide.
- In-licensing
- Browse
Licensing opportunities
Are you a small to medium company seeking a UK presence? More
UK partner for strategic divestments More
Strategic divestments of primary care sales focussed brands More
A global OTC drug products group with offices in the UK is seeking orally delivered modified release drug delivery systems that extend the efficacy of active pharmaceutical ingredients (APIs), which are susceptible to a large first-pass metabolism. More
Phase III and beyond prescription products are sought to in-license into the four major Nordic countries. More
Leiras Finland is looking to in-license new prescription products for the Nordic region including Finland, Sweden, Norway and Denmark. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Apr 2010 - 510 pages - $2,695
May 2011 - 5 pages - $500
Nov 2010 - 36 pages - $500
Apr 2011 - 22 pages - $1,895
Aug 2008 - 117 pages - $2,350
Feb 2011 - 412 pages - $395
Mar 2011 - 26 pages - $1,895
Oct 2010 - 598 pages - $2,695
Aug 2011 - 21 pages - $1,895
Mar 2008 - 100 pages - $3,800
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Anorexia
- Anti-oxidant
- Appetite
- Bulimia nervosa
- Cachexia
- Cirrhosis
- Diabetes type I
- Diabetes type II
- Diabetic complications
- Fabry's disease
- Gallbladder disorder (other)
- Gallstones
- Gaucher's disease
- Hepatic protectors
- Hepatic protectors
- Hypercholesterolemia
- Hyperparathyroidism
- Hypertriglyceridemia
- Liver cancer
- Liver disorders (other)
- Metabolic disorder (other)
- Mineral supplement
- Obesity
- Weight loss
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us